http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102391138-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7beaa3e0d121afbb4f783c6ed70a05de
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-582
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C227-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-08
filingDate 2011-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63ae10d85bcfe087c6116a8e16ac896e
publicationDate 2014-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102391138-B
titleOfInvention Method for preparing D-valine by using asymmetric transformation method
abstract The invention belongs to the technical field of chiral amino-acid compound preparation, and specifically relates to a method for preparing D-valine by using an asymmetric transformation method. The method is implemented through the following steps of: carrying out asymmetric transformation on a chiral resolution reagent (+)-1-phenyl ethanesulfonic acid and a dl-valine under the catalytic action of a solvent and a catalyst so as to obtain a corresponding target double salt solution; and sequentially carrying out separation, washing and dissociation on the obtained target double salt solution so as to obtain the D-valine, wherein the total yield is more than 90%, the resolution reagent (+)-1-phenyl ethanesulfonic acid can be recycled, and a mother solution also can be reapplied to the next asymmetric transformation process. By using the method provided by the invention, a racemization step in a classical resolution method is saved, the loss of another enantiomers is avoided, the resolution efficiency is improved, the operation is simplified, and an entrained separation phenomenon caused by that the concentration of enantiomers is increased in the classical resolution method is avoided, so that the optical purity (greater than 99% ee) of the D-valine is ensured. The chiral reagent and the mother solution can be recycled, so that the production cost is greatly lowered, therefore, the method provided by the invention is suitable for industrial production processes.
priorityDate 2011-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0119804-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID768
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409092530
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408497310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71563
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396422
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558386
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558411
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553602
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451829787
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559052
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID75969
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6569
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419480933
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID264
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10997746
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453034310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1032
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1182
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559065
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419545706
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16666
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31374
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396473
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID760
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413807576
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420307350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410778979
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556620
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516892
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23696331
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6998
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15413
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419539429
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415758420

Total number of triples: 60.